Kite Pharma, Inc. 4
4 · Kite Pharma, Inc. · Filed Jun 8, 2016
Insider Transaction Report
Form 4
DOUMANI ROY
Director
Transactions
- Sale
Common Stock
2016-06-06$58.38/sh−4,000$233,516→ 27,865 total(indirect: By Spouse) - Sale
Common Stock
2016-06-06$58.25/sh−5,000$291,260→ 136,017 total - Sale
Common Stock
2016-06-06$57.56/sh−5,000$287,805→ 131,017 total